Press release
Antiplatelet Drugs Market Set to Surge with Innovations in Stroke & Heart Attack Prevention by 2033 | Top key players - Sanofi, AstraZeneca., Eli Lilly and Company.
Antiplatelet Drugs Market
The Antiplatelet Drugs Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/antiplatelet-drugs-market?sz
The Antiplatelet Drugs Market comprises pharmaceutical agents that inhibit platelet aggregation and prevent blood clot formation, primarily used in cardiovascular disease management. These drugs reduce the risk of stroke, heart attacks, and other thrombotic events. Growing prevalence of heart-related conditions, increasing geriatric population, and advancements in drug formulations are key factors driving the market's expansion globally.
Prominent Industry players in the Antiplatelet Drugs Market
The prominent players in Antiplatelet Drugs market research report are: Sanofi, AstraZeneca., Eli Lilly and Company, Chiesi USA, Inc., Healing Pharma India Pvt. Ltd., Taj Pharmaceuticals Limited., Merck & Co., Inc., Otsuka Pharmaceutical Company, Ltd., Boehringer Ingelheim International GmbH, and AdvaCare Pharma among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Industry News
In August 2022, Bristol Myers Squibb, in partnership with Janssen Pharmaceuticals, reported results from the Phase 2 AXIOMATIC-SSP dose-ranging study of milvexian, an investigational oral factor XIa (FXIa) inhibitor. The study showed that combining milvexian with standard antiplatelet therapy led to an approximately 30% reduction in the relative risk of recurrent symptomatic ischemic strokes compared to placebo. These findings are particularly significant for patients recovering from acute non-cardioembolic ischemic stroke or transient ischemic attack (TIA).
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/antiplatelet-drugs-market
Market Segments
By Drug Class: Adenosine Diphosphate (ADP) Receptor Inhibitors, Irreversible Cyclooxygenase (COX) Inhibitors (Aspirin), Glycoprotein IIb/IIIa Inhibitors, Adenosine Reuptake Inhibitors (Dipyridamole), Phosphodiesterase Inhibitors (Cilostazol), Protease-Activated Receptor-1 Antagonists (Vorapaxar), Thromboxane Inhibitors (Triflusal).
By Route of Administration: Oral, Parenteral.
By Application: Myocardial Infarction, Percutaneous Coronary Interventions (PCI), Arterial Thrombosis, Stroke Prevention, Peripheral Artery Disease (PAD), Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
The Antiplatelet Drugs industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.
Regions Covered:
The global Antiplatelet Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
FAQs:
✒ What is driving the growth of the Antiplatelet Drugs Market?
✒ Who are the prominent players in the Antiplatelet Drugs Market?
✒ How is the regulatory landscape affecting the Antiplatelet Drugs Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Antiplatelet Drugs Market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Looking for Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=antiplatelet-drugs-market?sz
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antiplatelet Drugs Market Set to Surge with Innovations in Stroke & Heart Attack Prevention by 2033 | Top key players - Sanofi, AstraZeneca., Eli Lilly and Company. here
News-ID: 4082523 • Views: …
More Releases from DataM Intelligence 4Market Research
Revolutionizing Diabetes Care: Continuous Glucose Monitoring Market Surges with …
The Continuous Glucose Monitoring Market is expected to grow at a CAGR of 22% during the forecast period 2024-2031.
The Continuous Glucose Monitoring Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with…
Body Contouring Devices Market Predicted to Reach USD 4,039.26 Million by 2031 | …
The Body Contouring Devices Market was valued at US$ 1,671.35 million in 2022 and is estimated to reach US$ 4,039.26 million by 2031, growing at a CAGR of 15.8% during the forecast period (2024-2031).
The Body Contouring Devices Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading…
Breakthroughs Reshape Alopecia Medication Market: Surging Demand, Innovations, a …
The Global Alopecia Medication Market was valued at US$ 8.7 Billion. The global alopecia medication market size reached US$ 9.42 Billion in 2024 and is expected to reach US$ 20.49 Billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.
The Alopecia Medication Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores…
Contract Research Organization Market Set to Soar: Driving Innovation and Accele …
The Contract Research Organization Market was valued at US$ 59,923.29 million in 2021 and is estimated to reach US$ 170,427.41 million by 2031, growing at a CAGR of 13.58% during the forecast period (2024-2031).
The Contract Research Organization Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
